BIVINasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as BIVIW
BIOVIE INC.
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Aug 13, 2026
$1.37+0.17 (+14.17%)
Close on Oct 19, 2026
- Market cap
- $10.86M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.54 (−28.27%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $10.86M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 1.06
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$22.07M
- EPS, diluted
- -$3.05
- Book value per share
- $1.30
- Diluted shares
- 8M
Fourteen years at a glance
Fiscal years 2013 to 2026, USD
Operating income
-$22.65M
Net income
-$22.07M
EPS, diluted
-$3.05
Reported period